vs
Side-by-side financial comparison of Beacon Financial Corp (BBT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $216.7M, roughly 1.4× Beacon Financial Corp). Beacon Financial Corp runs the higher net margin — 24.6% vs 12.8%, a 11.8% gap on every dollar of revenue. Over the past eight quarters, Beacon Financial Corp's revenue compounded faster (41.2% CAGR vs 4.2%).
Beacon Roofing Supply, Inc. is an American company which sells residential and non-residential roofing products, as well as related building products in North America. As of December 31, 2023, the company had 533 locations throughout all 50 states in the U.S. and six Canadian provinces, and over 8,000 employees. In addition to roofing, local divisions may also sell windows, siding, decking, waterproofing and other external building products. The company is currently headquartered in Herndon, ...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
BBT vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $216.7M | $295.9M |
| Net Profit | $53.4M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | — | 18.4% |
| Net Margin | 24.6% | 12.8% |
| Revenue YoY | — | -6.4% |
| Net Profit YoY | 179.4% | 68.3% |
| EPS (diluted) | $0.55 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $216.7M | — | ||
| Q4 25 | $225.7M | $295.9M | ||
| Q3 25 | $141.2M | — | ||
| Q2 25 | $113.7M | $317.0M | ||
| Q1 25 | $110.4M | $316.2M | ||
| Q4 24 | $110.2M | $297.0M | ||
| Q3 24 | $125.6M | $289.5M | ||
| Q2 24 | $108.7M | $306.1M |
| Q1 26 | $53.4M | — | ||
| Q4 25 | $53.4M | $38.0M | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $22.0M | $-17.7M | ||
| Q1 25 | $19.1M | $22.6M | ||
| Q4 24 | $17.5M | $34.9M | ||
| Q3 24 | $20.1M | $33.6M | ||
| Q2 24 | $16.4M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 18.4% | ||
| Q3 25 | -5.9% | — | ||
| Q2 25 | 26.0% | -7.5% | ||
| Q1 25 | 23.1% | 12.2% | ||
| Q4 24 | 21.6% | 16.0% | ||
| Q3 24 | 21.3% | 13.8% | ||
| Q2 24 | 19.9% | 15.0% |
| Q1 26 | 24.6% | — | ||
| Q4 25 | 23.6% | 12.8% | ||
| Q3 25 | -3.0% | — | ||
| Q2 25 | 19.4% | -5.6% | ||
| Q1 25 | 17.3% | 7.1% | ||
| Q4 24 | 15.9% | 11.7% | ||
| Q3 24 | 16.0% | 11.6% | ||
| Q2 24 | 15.1% | 13.3% |
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.64 | $0.24 | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | $0.25 | $-0.11 | ||
| Q1 25 | $0.21 | $0.14 | ||
| Q4 24 | $0.20 | $0.22 | ||
| Q3 24 | $0.23 | $0.21 | ||
| Q2 24 | $0.18 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $927.3M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $2.5B | $2.0B |
| Total Assets | $22.2B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $927.3M | — | ||
| Q4 25 | $1.8B | $172.9M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | $543.7M | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | — | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $225.6M | $346.0M | ||
| Q1 25 | $284.6M | $330.0M | ||
| Q4 24 | $1.5B | $300.0M | ||
| Q3 24 | $353.6M | $300.0M | ||
| Q2 24 | $278.6M | $319.0M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.0B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.2B | $2.1B |
| Q1 26 | $22.2B | — | ||
| Q4 25 | $23.2B | $2.5B | ||
| Q3 25 | $22.8B | — | ||
| Q2 25 | $12.0B | $2.6B | ||
| Q1 25 | $12.0B | $2.6B | ||
| Q4 24 | $11.9B | $2.7B | ||
| Q3 24 | $11.6B | $2.7B | ||
| Q2 24 | $12.2B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.18× | 0.18× | ||
| Q1 25 | 0.24× | 0.16× | ||
| Q4 24 | 1.24× | 0.14× | ||
| Q3 24 | 0.29× | 0.14× | ||
| Q2 24 | 0.23× | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBT
| Net Interest Income | $190.8M | 88% |
| Noninterest Income | $25.9M | 12% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
